Law & Health Weekly, January 9, 2010, Saturday

Copyright 2010 Law & Health Weekly via LawRx.com via NewsRx.com and NewsRx.net
Law & Health Weekly

January 9, 2010, Saturday

HEADLINE: HALLORAN CONSULTING GROUP; Halloran Consulting Group Further Expands Executive Team, Offering New Services to Clients

BODY:
Halloran Consulting Group (HCG), a firm that specializes in clinical development strategy and services for estab-lished and emerging life sciences companies, announced the continued expansion of its senior executive team, with the addition of Vicky Hines, Ph.D., as a Principal Consultant, and Walter Houseman, as a Consultant. The addition of these two senior executives enhances Halloran's service offering, further increasing the firm's ability to provide strategic planning and program management to early-stage biotech and pharmaceutical companies, as well as its expertise in operational and infrastructure management (see also Halloran Consulting Group).

"Both Vicky and Walter bring complementary areas of expertise in their prior life science careers and we are very pleased to bring them into our firm to augment our existing strengths across the product development space," said Lau-rie Halloran, President and CEO of HCG. "Over the past year our firm has doubled in size, which underscores the value our clients continue to receive as they seek more novel ways of creating and executing development strategies that are seamlessly integrated with senior level quality and regulatory services, leveraging technology whenever possible to save both time and money."

"With steep regulatory challenges, and a difficult fiscal environment, there is no room for error in either design or conduct," Halloran continued. "Companies are recognizing the importance of strong clinical development programs from the earliest stages, realizing that the old high-cost methods for getting there won't work anymore."

Prior to joining Halloran Consulting, Dr. Hines was Therapeutic Director at Celtic Pharma - a healthcare-focused private equity fund - where she had strategic and operational oversight of oncology and vaccines programs. At Celtic, Dr. Hines led virtual global project teams, making key sourcing decisions and selecting and managing external vendors for different projects. This experience gave her a strong understanding of the opportunities and challenges associated with virtual development teams. Prior to her work at Celtic, Dr. Hines worked at Chiron Corporation for 15 years, where she held positions in regulatory affairs, toxicology, program management, strategic planning, European commercial operations, and as the Senior Director of Project Management. Vicky earned a B.A. in Biology from Carleton College and a Ph.D. in Biochemistry from the University of Chicago.

Before joining HCG, Mr. Houseman was the Vice President of Operations for CRF Health, Inc. CRF provides electronic diaries to investigator sites and patients in the pharmaceutical and biotechnology markets. Prior to his opera-tions role, Walter held positions at Perceptive Informatics, CRF Box Ltd., and Clinsoft Corporation in program and project management, where he evaluated various clinical development functions, including clinical protocols, resourc-ing, quality standards, global vendors, clinical trial management systems, adverse event safety software, web-based recruitment tools, and wireless clinical trial applications. Walter received a B.S. in Labor Relations from Cornell University. About Halloran Consulting Group Halloran is a management consulting firm specializing in the biopharmaceutical arena, providing strategic oversight and tactical implementation of clinical, quality and regulatory services. Halloran partners with companies that develop and bring life-saving therapies to the people who need them by helping them evaluate, hire and manage their CRO, while building organizational infrastructure, regulatory and quality frameworks. Halloran applies wisdom from hundreds of clinical and regulatory submissions to ensure capital efficient drug devel-opment, and improves the process by developing and implementing innovative strategies that will make drug develop-ment more cost-effective and will help deliver more life-saving therapies to a broader reach of patients, faster.

For more information, visit www.hallorancg.com or call us at 781-209-5440.

Keywords: Biochemistry, Biotechnology, Chemicals, Chemistry, Conservation, Consulting, Cornell University, Ecology, Environment, Finance, Health, Investing, Investment, Mutual Funds, Oncology, Other Professional Services, Other Science, Pharmaceutical, Pharmaceuticals, Private Equity, Private Equity Fund, Professional Services, Science, Software, Technology, Therapy, Toxicology, Treatment, Vaccines, Halloran Consulting Group.

This article was prepared by Law & Health Weekly editors from staff and other reports. Copyright 2010, Law & Health Weekly via NewsRx.com.

LOAD-DATE: December 31, 2009